Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof
US11485787B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 5, 2015 |
| Grant date | Nov 1, 2022 |
| Priority date | — |
| Expiry date | Feb 5, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for the modulation RGMb-Neogenin-BMP signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.